Biomerica Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Biomerica, Inc. (BMRA) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2019FY 2018
Period EndingDec 2025May 2024May 2023May 2022May 2021May 2019May 2018
Operating Activities
Net Income-4.97-5.98-7.14-4.53-7.45-2.39-1.47
Depreciation & Amortization0.400.370.350.600.380.160.19
Deferred Income Tax0.000.000.000.000.000.010.03
Stock Based Compensation0.460.841.191.261.350.000.00
Change in Working Capital0.27-0.040.303.60-1.85-0.190.03
Change in Accounts Receivable0.21-0.22-0.291.37-0.460.000.00
Change in Inventory0.88-0.120.531.56-1.910.000.00
Change in Accounts Payable-0.470.25-0.080.39-0.400.000.00
Change in Other Working Capital-0.36-0.30-0.200.280.910.000.00
Other Operating Activities0.000.331.06-0.441.550.010.02
Net Cash from Operating Activities-3.84-5.36-5.47-0.48-5.25-2.24-1.17
Investing Activities
Capital Expenditures-0.040.12-0.08-0.17-0.14-0.10-0.13
Sales/Maturities of Investments0.00-0.06-0.01-0.11-0.160.000.00
Net Cash from Investing Activities-0.04-0.12-0.08-0.17-0.30-0.17-0.13
Financing Activities
Common Stock Issued2.140.0010.012.401.281.781.27
Common Stock Repurchased0.000.00-0.71-0.090.000.000.00
Other Financing Activities-0.03-0.08-0.71-0.09-0.170.010.00
Net Cash from Financing Activities2.11-0.089.392.391.111.911.29
Summary
Effect of Forex Changes on Cash0.000.01-0.04-0.03-0.01-0.01-0.01
Net Change in Cash-1.77-5.563.841.74-4.44-0.51-0.01
Cash at Beginning of Period4.179.725.924.208.641.201.23
Cash at End of Period2.404.179.725.9212.840.691.20
Free Cash Flow-3.88-5.48-5.55-0.65-5.39-2.42-1.30
Supplemental Disclosures
Interest Paid0.000.000.000.000.000.000.00
Income Taxes Paid0.010.040.050.020.030.010.00